Alphabet's Verily wants to be at the center of the medical start-up ecosystem, both literally and figuratively.
The company, formerly known as Google Life Sciences, is now offering entrepreneurs access to its South San Francisco-based lab space, office space, talent and other resources in exchange for equity or cash.
"We want to have cutting-edge tech companies working in health care proximate to us," said Verily's business development lead Andrew Harrison.
CNBC first reported on a partner start-up moving onto the Verily campus in July, but the full details were not yet public.
Alphabet has many vehicles for investing in start-ups, including GV, which invests in early-stage companies, and CapitalG, which is focused on later-stage companies.
But lately, it has been specializing more. Most recently, it launched Gradient Ventures earlier this year to fund early-stage artificial intelligence companies and bolster access to Google's engineering talent.
Verily's model is tailored to the medical sector, which represents about a fifth of the economy. Alphabet, alongside Apple, Microsoft and Amazon, are all looking to slice out a piece of this $3 trillion health care pie.